(Q37980021)

26 August 2017

title

Osteoblastogenesis regulation signals in bone remodeling (English)

1 reference

26 August 2017

C Zuo

1

1 reference

26 August 2017

Y Huang

2

1 reference

26 August 2017

R Bajis

3

1 reference

26 August 2017

M Sahih

4

1 reference

26 August 2017

Y-P Li

5

1 reference

26 August 2017

K Dai

6

1 reference

26 August 2017

X Zhang

7

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

Osteoporosis International

26 August 2017

published in

1 reference

26 August 2017

volume

23

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

1653-1663

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-012-1909-x

26 August 2017

exact match

0 references

cites work

Osteoporosis: impact on health and economics

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Mechanisms of anabolic therapies for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Building bone to reverse osteoporosis and repair fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Transforming growth factor-beta1 to the bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

The BMP signaling and in vivo bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Effects of transforming growth factor-beta deficiency on bone development: a Fourier transform-infrared imaging analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Transforming growth factor-beta 3 is required for secondary palate fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Osteoblastic responses to TGF-beta during bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Bone: formation by autoinduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Novel regulators of bone formation: molecular clones and activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Bone morphogenetic proteins, their antagonists, and the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Skeletal overexpression of gremlin impairs bone formation and causes osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Regulation of bone mass by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

High bone mass in mice expressing a mutant LRP5 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Regulation of osteoblastogenesis and bone mass by Wnt10b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Sequential roles of Hedgehog and Wnt signaling in osteoblast development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Secreted antagonists of the Wnt signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Notch signaling in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Skeletal and CNS defects in Presenilin-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Mutations in the human Jagged1 gene are responsible for Alagille syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Dimorphic effects of Notch signaling in bone homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Eph and ephrin interactions in bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Parathyroid hormone is essential for normal fetal bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

PTH and PTHrP signaling in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

SOST is a target gene for PTH in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Serum leptin level is a regulator of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Leptin regulates bone formation via the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

The molecular clock mediates leptin-regulated bone formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Leptin regulation of bone resorption by the sympathetic nervous system and CART

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Fracture risk in perimenopausal women treated with beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Lrp5 functions in bone to regulate bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Skeletal Overexpression of Noggin Results in Osteopenia and Reduced Bone Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1909-X

Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass

21 January 2018

1 reference

12 December 2020

Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid

1 reference

12 December 2020

Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact

1 reference

12 December 2020

TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes

1 reference

12 December 2020

Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells

1 reference

12 December 2020

Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers

1 reference

12 December 2020

beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures

1 reference

12 December 2020

Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow

1 reference

12 December 2020

Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis

1 reference

12 December 2020

Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts

1 reference

12 December 2020

Effect of transforming growth factor β on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cells

1 reference

12 December 2020

Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development

1 reference

12 December 2020

TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling

1 reference

12 December 2020

Parathyroid hormone regulates transforming growth factor beta1 and beta2 synthesis in osteoblasts via divergent signaling pathways

1 reference

12 December 2020

Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes

1 reference

12 December 2020

Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae

1 reference

12 December 2020

10.1007/S00198-012-1909-X

Identifiers

DOI

1 reference

26 August 2017

1 reference